Clinical Trial Update: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS [Phase 1, Phase 2]

View source ↗

Summary

This Clinical Trials update describes a Phase 1/Phase 2 trial evaluating intratumoral injection of IP-001 following thermal ablation in patients with metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Non-small Cell Lung Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• IP-001 (IP-001)

Snippet

Sponsor: Immunophotonics, Inc. | Conditions: Metastatic Solid Tumor, Colon Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING